A method for assessing clinically relevant individual cognitive change in older adult populations

Journals of Gerontology - Series B Psychological Sciences and Social Sciences

Volumn 54, Issue 2, 1999, Pages

  Sawrie, Stephen M ^a   Marson, Daniel C ^a,b,c   Boothe, Amy L ^a   Harrell, Lindy E ^a,b,c  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; DIAGNOSTIC VALUE; FUNCTIONAL ASSESSMENT; HUMAN; LANGUAGE; PRIORITY JOURNAL; SCORING SYSTEM; VERBAL MEMORY;

EID: 0032935140     PISSN: 10795014     EISSN: None     Source Type: Journal    
DOI: 10.1093/geronb/54B.2.P116     Document Type: Article

References (61)

1. Albert, M. S., & Heaton, R. K. (1988). Intelligence testing. In M. S. Albert & M. B. Moss (Eds.), Geriatric neuropsychology. New York: Guilford.
2. Antuono, P. G. (1995). Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease: A double-blind, placebo-controlled study. Mentane Study Group. Archives of Internal Medicine, 155, 1766-1772.
3. Arenberg, D. (1983). Estimates of age changes on the Benton Visual Retention Test. Journal of Gerontology, 37, 87-90.
4. Benton, A. L., & Hamsher, K. deS. (1989). Multilingual aphasia examination. Iowa City, IA: AJA Associates.
5. Birren, J. E., & Schaie, K. W. (Eds.). (1996). Handbook of the psychology of aging. New York: Academic Press.
6. Bodenburg, S., & Technow, U. (1992). Neuropsychological therapy at the computer with the elderly. Zeitschrift fur Genotologie, 25, 255-258.
7. Bodick, N. C., Offen, W. W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., Hurley, D. J., Potter, W. Z., & Paul, S. M. (1997). Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer's disease. Archives of Neurology, 54, 465-473.
8. Botwinick, J. (1977). Intellectual abilities. In J. E. Birren & K. W. Schaie (Eds.), Handbook of the psychology of aging. New York: Van Nostrand.
9. Bryson, H. M., & Benfield, P. (1997). Donepezil. Drugs & Aging, 10(3), 234-239.
10. Butters, M., Salmon, D., & Butters, N. (1994). Neuropsychological assessment of dementia. In M. Storandt & G. VandenBos (Eds.), Neuropsychological assessment of dementia and depression in older adults: A clinician's guide (pp. 33-59). Washington, DC: American Psychological Association.
11. Chelune, G. J. (1998, February). Reliable neuropsychological change: An elaboration of methods for assessing meaningful change. Presentation made at the Annual Meeting of the International Neuropsychological Society, Honolulu, HI.
12. Chelune, G. J., Naugle, R. I., Lüders, H., Sedlak, J., & Awad, I. A. (1993). Individual change after epilepsy surgery: Practice effects and base-rate information. Neuropsychology, 7(1), 41-52.
13. Colsher, P. L., & Wallace, R. B. (1991). Longitudinal application of cognitive function measures in a defined population of community-dwelling elders. Annals of Epidemiology, 1, 215-230.
14. Cornelius, S. W. (1984). Classic patterns of intellectual aging: Test familiarity, difficulty, and performance. Journal of Gerontology, 39, 201-206.
15. Cronbach, L. J., & Furby, L. (1970). How should we measure "change" - or should we? Psychological Bulletin, 74, 68-80.
16. Cronin-Golomb, A., Corkin, S., & Rosen, T. J. (1993). Neuropsychological assessment of dementia. In P. J. Whitehouse (Ed.), Dementia (pp. 130-164). Philadelphia: F. A. Davis Company.
17. Cullum, C. M., Butters, N., Troster, A. I., & Salmon, D. P. (1990). Normal aging and forgetting rates on the Wechsler Memory Scale-Revised. Archives of Clinical Neuropsychology, 5, 23-30.
18. Flicker, C., Ferris, S. H., & Reisberg, B. (1993). A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease. Journal of Geriatric Psychiatry & Neurology, 6(2), 84-96.
19. Furby, I. (1973). Interpreting regression toward the mean in developmental research. Developmental Psychology, 8, 172-179.
20. Giambra, L. M., Arenberg, D., Zonderman, A. B., Kawas, C., & Costa, P. T. (1995). Adult life-span changes in immediate visual memory and verbal intelligence. Psychology and Aging, 10, 123-139.
21. Gonzalez-Torrecillas, J. L., Mendlewicz, J., & Lobo, A., (1995). Effects of early treatment of poststroke depression on neuropsychological rehabilitation. International Psychogeriatrics, 7, 547-560.
22. Heiss, W. D., Kessler, J., Mielke, R., Szelies, B., & Herholz, K. (1994). Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. Dementia, 5(2), 88-98.
23. Hermann, B. P., Seidenberg, M., Schoenfeld, J., Peterson, J., Leveroni, C., & Wyler, A. P. (1996). Empirical techniques for determining the reliability, magnitude, and pattern of neuropsychological change after epilepsy surgery. Epilepsia, 37, 942-950.
24. Hermann, B. P., Wyler, A. P., Vanderzwagg, R., LeBailly, R. K., Whitman, S., James, G., & Ward, J. (1991). Predictors of neuropsychological change following anterior temporal lobectomy: Role of regression toward the mean. J. Epilepsy, 4, 139-148.
25. Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59(1), 12-19.
26. Kaplan, E. F., Goodglass, H., & Weintraub, S. (1983). The Boston Naming Test. Boston: Kaplan & H. Goodglass.
27. Laird, N. (1983). Further comparative analyses of pretest-postest research designs. American Statistician, 37, 329-330.
28. Lezak, M. D. (1995). Neuropsychological assessment (3rd ed.). New York: Oxford University Press.
29. Mack, J. L., & Carlson, N. J. (1978). Conceptual deficits and aging: The category test. Perceptual and Motor Skills, 46, 123-128.
30. Malec, J. F., Ivnik, R. J., & Smith, G. E. (1993). Neuropsychology and normal aging: The clinician's perspective. In R. Parks, R. F. Zec., & R. S. Wilson (Eds.), Neuropsychology of AD and other dementias (pp. 81-111). New York: Oxford University Press.
31. Matarazzo, J. D., Carmody, T. P., & Jacobs, L. D. (1980). Test-retest reliability and stability of the WAIS: A literature review with implications for clinical practice. Journal of Clinical Neuropsychology, 6, 351-266.
32. Mattis, S. (1976). Mental status examination for organic mental syndrome in the elderly patient. In L. Bellack & T.B. Karusu (Eds.), Geriatric psychiatry (pp. 77-121). New York: Grune & Stratton.
33. Mattis, S. (1988). Dementia Rating Scale professional manual. Odessa, FL: Psychological Assessment Resources.
34. McCaffrey, R., J., Ortega, A., & Haase, R. F. (1993). Effects of repeated neuropsychological assessments. Archives of Clinical Neuropsychology, 8, 519-524.
35. McCaffrey, R. J., Ortega, A., Orsillo, S. M., Nelles, W. B., & Haase, R. F. (1992). Practice effects in repeated neuropsychological assessments. The Clinical Neuropsychologist, 6(1), 32-42.
36. McCarty, S. M., Siegler, I. C., & Logue, P. E. (1982). Cross-sectional and longitudinal patterns of three Wechsler Memory Scale subtests. Journal of Gerontology, 37, 169-175.
37. McDonald-Misczcak, L. A., Hertzog, C., & Hultsch, D. F. (1995). Stability and accuracy of metamemory in adulthood and aging: A longitudinal analysis. Psychology and Aging, 10, 553-564.
38. McSweeney, A. J., Naugle, R. I., Chelune, G. C., & Lüders, H. (1993). "T scores for change": An illustration of a regression approach to depicting change in clinical neuropsychology. The Clinical Neuropsychologist, 7, 300-312.
39. Nesselroade, J. R., Stigler, S. M., & Baltes, P. B. (1980). Regression toward the mean and the study of change. Psychological Bulletin, 88, 622-637.
40. Perlmutter, M., & Nyquist, L. (1990). Relationships between self-reported physical and mental health and intelligence performance across adulthood. Journal of Gerontology: Psychological Sciences, 45, P145-P155.
41. Psychological Corporation. (1997). The WAIS-III and WMS-III technical manual. San Antonio, TX: Author.
42. Raskind, M. A., Sadowsky, C. H., Sigmund, W. R., Beitler, P. J., & Auster, S. B. (1997). Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer's disease. Archives of Neurology, 54, 836-840.
43. Reitan, R. M., & Wolfson, D. (1993). The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation (2nd ed.). Tucson, AZ: Neuropsychology Press.
44. Rockwood, K., Beattie, B. L., Eastwood, M. R., Feldman, H., Mohr, E., Pryse-Phillips, W., & Gauthier, S. (1997). A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease. Canadian Journal of Neurological Sciences, 24, 140-145.
45. Rogers, S. L., & Friedhoff, L. T. (1996). The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicenter, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group. Dementia, 7(6), 293-303.
46. Rybash, J. M., Roodin, P. A., & Hoyer, W., J. (1995). Adult development and aging (3rd ed.). Dubuque, IA: Brown & Benchmark Publishers.
47. Salthouse, T. A. (1982). Adult cognition: An experimental psychology of human aging. New York: Springer.
48. Sawrie, S. M., Chelune, G. C., Naugle, R. I., & Lüders, H. O. (1996). Empirical methods for assessing meaningful neuropsychological change following epilepsy surgery. Journal of the International Neuropsychological Society, 2, 556-564.
49. Schaie, K. W. (1994). The course of intellectual developement. American Psychologist, 49, 304-313.
50. Smith, S. R., Murdoch, B. E., & Chenery, H. J. (1989). Semantic abilities in dementia of the Alzheimer type: 1. Lexical semantics. Brain and Language, 36, 314-324.
51. Speer, D. C. (1992). Clinically significant change: Jacobson and Truax (1991) revisited. Journal of Consulting and Clinical Psychology, 60, 402-408.
52. Spreen, O., & Strauss, E. (1991). A compendium of neuropsychological tests. New York: Oxford University Press.
53. Talwalker, S. (1996). The cardinal features of cognitive and noncognitive dysfunction and the differential efficacy of tacrine in Alzheimer's disease patients. Journal of Biopharmaceutical Statistics, 6, 443-456.
54. Wechsler, D. (1981). WAIS-R manual. New York: The Psychological Corporation.
55. Wechsler, D. (1987). Wechsler Memory Scale-Revised manual. San Antonio, TX: The Psychological Corporation.
56. Weschler, D. (1997). The Wechsler Memory Scale-III manual. San Antonio, TX: The Psychological Corporation.
57. Wilson, B. (1982). Success and failure in memory training following a cerebral vascular accident. Cortex, 18, 581-594.
58. Zelinski, E. M., & Burnight, K. P. (1997). Sixteen-year longitudinal and time lag changes in memory and cognition in older adults. Psychology and Aging, 12, 503-513.
59. Zelinski, E. M., Gilewski, M. J., & Schaie, K. W. (1993). Individual differences in cross-sectional and 3-year longitudinal memory performance across the adult life span. Psychology and Aging, 8, 176-186.
60. Zemlan, F. P. (1996). Velnacrine for the treatment of Alzheimer's disease: A double-blind, placebo-controlled trial. The Mentane Study Group. Journal of Neural Transmission, 103, 1105-1116.
61. Zemlan, F. P., Keys, M., Richter, R. W., & Strub, R. L. (1996). Double-blind placebo-controlled study of velnacrine in Alzheimer's disease. Life Sciences, 58, 1823-1832.